Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: FET-PET for Evaluation of Response of Recurrent GBM to Avastin [Phase 2]
Phase 2 trial evaluating FET-PET to assess response of recurrent glioblastoma to Avastin has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma [Phase 2]
Phase 2 study of durvalumab (MEDI4736) in glioblastoma has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: An Efficacy Study Of Ortataxel In Recurrent Glioblastoma [Phase 2]
Phase 2 trial update on Ortataxel for recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
Phase 1b/2 trial evaluating PLX3397 with radiation therapy and temozolomide in newly diagnosed glioblastoma has completed; results were post…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Improving Goals of Care Discussion in Advanced Cancer Patients [NA]
Clinical trial update reporting completion and results posting for a study focused on improving goals of care discussions in advanced cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Enzastaurin Versus Lomustine in Glioblastoma [Phase 3]
A Phase 3 clinical trial comparing enzastaurin to lomustine in glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas [Phase 1]
Phase 1 trial evaluating alisertib in combination with fractionated stereotactic radiosurgery for adults with recurrent high-grade gliomas h…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII [Phase 1, Phase 2]
Phase 1/2 trial of EGFRvIII-targeted CAR T cell therapy for malignant gliomas expressing EGFRvIII has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating LY2228820 with radiotherapy and temozolomide in newly diagnosed glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform [Phase 1, Phase 2]
Phase 1-2 study of temozolomide with hypofractionated radiotherapy for supratentorial glioblastoma multiforme has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib [Phase 1, Phase 2]
Clinical study evaluating anlotinib for recurrent glioblastoma across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating a vaccine therapy with bevacizumab versus bevacizumab alone in patients with surgically resectable recurrent gliobl…
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma [Phase 2]
Phase 2 study evaluating TRC105 in combination with bevacizumab in glioblastoma completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma [Phase 1, Phase 2]
Phase I/II trial comparing bevacizumab alone versus bevacizumab plus TPI-287 for recurrent glioblastoma; trial terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery [Phase 2]
Phase 2 safety study of aminolevulinic acid to improve visualization of brain tumors during surgery (glioblastoma) has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating MRI and PET/FMISO imaging to assess tumor hypoxia in patients with newly diagnosed glioblastoma multiforme…
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma [Phase 2]
Phase 2 trial evaluating enzastaurin with radiation followed by enzastaurin in newly diagnosed glioblastoma; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial of methoxyamine and temozolomide in recurrent glioblastoma (terminated; results posted).
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme [NA]
A completed clinical trial evaluating 89Zr-J591 anti-PSMA antibody in patients with glioblastoma multiforme; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform [Phase 1]
Phase 1 open-label trial to evaluate the safety of combining Afatinib with radiotherapy, with or without temozolomide, in newly diagnosed gl…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma [Phase 1, Phase 2]
A Phase 1/2 study of intraventricular liposomal cytarabine (DepoCyt) for recurrent glioblastoma was terminated, and results have been posted…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Spectral Analysis Probe to Identify Glioblastoma Cells
A University of Oklahoma-sponsored clinical trial evaluating a spectral analysis probe to identify glioblastoma cells has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma [Phase 2]
A randomized Phase II study evaluated axitinib as a monotherapy or in combination with lomustine for recurrent glioblastoma; the trial has c…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma [Phase 2]
This update reports the completion of a Phase 2 trial evaluating the combination of Bavencio (avelumab) and Inlyta (axitinib) in patients wi…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Tivozanib for Recurrent Glioblastoma [Phase 2]
Phase 2 clinical trial update for tivozanib in recurrent glioblastoma has completed with results posted.